238 related articles for article (PubMed ID: 15579491)
1. mRNA analysis of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis using a real-time quantitative RT-PCR assay.
Ramón L; Gilabert-Estellés J; Castelló R; Gilabert J; España F; Romeu A; Chirivella M; Aznar J; Estellés A
Hum Reprod; 2005 Jan; 20(1):272-8. PubMed ID: 15579491
[TBL] [Abstract][Full Text] [Related]
2. Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis.
Gilabert-Estellés J; Estellés A; Gilabert J; Castelló R; España F; Falcó C; Romeu A; Chirivella M; Zorio E; Aznar J
Hum Reprod; 2003 Jul; 18(7):1516-22. PubMed ID: 12832381
[TBL] [Abstract][Full Text] [Related]
3. Expression of angiogenic factors in endometriosis: relationship to fibrinolytic and metalloproteinase systems.
Gilabert-Estellés J; Ramón LA; España F; Gilabert J; Vila V; Réganon E; Castelló R; Chirivella M; Estellés A
Hum Reprod; 2007 Aug; 22(8):2120-7. PubMed ID: 17609243
[TBL] [Abstract][Full Text] [Related]
4. Expression and localization of extracellular matrix-degrading proteinases and their inhibitors in the bovine mammary gland during development, function, and involution.
Rabot A; Sinowatz F; Berisha B; Meyer HH; Schams D
J Dairy Sci; 2007 Feb; 90(2):740-8. PubMed ID: 17235151
[TBL] [Abstract][Full Text] [Related]
5. In situ localization of mRNA for the fibrinolytic factors uPA, PAI-1 and uPAR in endometriotic and endometrial tissue.
Bruse C; Radu D; Bergqvist A
Mol Hum Reprod; 2004 Mar; 10(3):159-66. PubMed ID: 14981142
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA expression profile in endometriosis: its relation to angiogenesis and fibrinolytic factors.
Braza-Boïls A; Marí-Alexandre J; Gilabert J; Sánchez-Izquierdo D; España F; Estellés A; Gilabert-Estellés J
Hum Reprod; 2014 May; 29(5):978-88. PubMed ID: 24608518
[TBL] [Abstract][Full Text] [Related]
7. Influence of peritoneal fluid on the expression of angiogenic and proteolytic factors in cultures of endometrial cells from women with endometriosis.
Cosín R; Gilabert-Estellés J; Ramón LA; Gómez-Lechón MJ; Gilabert J; Chirivella M; Braza-Boïls A; España F; Estellés A
Hum Reprod; 2010 Feb; 25(2):398-405. PubMed ID: 19945964
[TBL] [Abstract][Full Text] [Related]
8. Quantitative real-time reverse transcription-PCR assay for urokinase plasminogen activator, plasminogen activator inhibitor type 1, and tissue metalloproteinase inhibitor type 1 gene expressions in primary breast cancer.
Castelló R; Estellés A; Vázquez C; Falcó C; España F; Almenar SM; Fuster C; Aznar J
Clin Chem; 2002 Aug; 48(8):1288-95. PubMed ID: 12142386
[TBL] [Abstract][Full Text] [Related]
9. [Expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 mRNA in endometriosis].
Li Y; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):30-3. PubMed ID: 16635325
[TBL] [Abstract][Full Text] [Related]
10. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
[TBL] [Abstract][Full Text] [Related]
11. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH
BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471
[TBL] [Abstract][Full Text] [Related]
12. The effect of IL-1alpha on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in osteoblastic ROS 17/2.8 cells.
Fujisaki K; Tanabe N; Suzuki N; Mitsui N; Oka H; Ito K; Maeno M
Life Sci; 2006 Mar; 78(17):1975-82. PubMed ID: 16313928
[TBL] [Abstract][Full Text] [Related]
13. [Expression of matrix metalloproteinase and tissue inhibitor of metalloproteinase in adenomyosis].
Qiu F; Gao XM; Luo GL; Yang KX; Wang H; Liu H; Wen Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):118-22. PubMed ID: 16468658
[TBL] [Abstract][Full Text] [Related]
14. Effects of hormones on uPA, PAI-1 and suPAR from cultured endometrial and ovarian endometriotic stromal cells.
Guan YM; Carlberg M; Bruse C; Carlström K; Bergqvist A
Acta Obstet Gynecol Scand; 2002 May; 81(5):389-97. PubMed ID: 12027810
[TBL] [Abstract][Full Text] [Related]
15. Expression and localisation of extracellular matrix degrading proteases and their inhibitors during the oestrous cycle and after induced luteolysis in the bovine corpus luteum.
Kliem H; Welter H; Kraetzl WD; Steffl M; Meyer HH; Schams D; Berisha B
Reproduction; 2007 Sep; 134(3):535-47. PubMed ID: 17709571
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of extracellular matrix components in the bovine oviduct during the oestrous cycle.
Gabler C; Killian GJ; Einspanier R
Reproduction; 2001 Jul; 122(1):121-30. PubMed ID: 11425336
[TBL] [Abstract][Full Text] [Related]
17. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T
Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653
[TBL] [Abstract][Full Text] [Related]
18. Gene expression of adhesion molecules and matrix metalloproteinases in endometriosis.
Ueda M; Yamashita Y; Takehara M; Terai Y; Kumagai K; Ueki K; Kanda K; Hung YC; Ueki M
Gynecol Endocrinol; 2002 Oct; 16(5):391-402. PubMed ID: 12587534
[TBL] [Abstract][Full Text] [Related]
19. Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential.
Nishikawa A; Iwasaki M; Akutagawa N; Manase K; Yamashita S; Endo T; Kudo R
Gynecol Oncol; 2000 Nov; 79(2):256-63. PubMed ID: 11063654
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and endometriosis. Influence of PAI-1 polymorphism on PAI-1 antigen and mRNA expression.
Ramón LA; Gilabert-Estellés J; Cosín R; Gilabert J; España F; Castelló R; Chirivella M; Romeu A; Estellés A
Thromb Res; 2008; 122(6):854-60. PubMed ID: 18423526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
